Hepatitis C

Once an incurable disease affecting 3.5 million Americans, Hepatitis C slowly attacks the liver, leading to cirrhosis and cancer.1 Today, patients suffering from this disease have access to an array of cures.

By 2011, Hepatitis C was costing the U.S. healthcare system upwards of $6.5 billion a year, with no end in sight.2 Treatment at the time required ongoing injections that carried debilitating side effects.

In 2014, a new drug was introduced that has delivered cure rates as high as 90% for Hepatitis C.3 The drug comes in pill form and is taken once a day for a 12-week course.

Hepatitis C represents one of the most compelling recent success stories for biotechnology — an innovation that is giving people their lives back and can lower long-term healthcare costs over time.

  1. https://www.hepmag.com/article/hep-C-prevalence-27774-1220668957;
    http://www.cdc.gov/media/releases/2016/p0504-hepc-mortality.html
  2. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356484/
  3. http://www.healthline.com/health-slideshow/liver-transplant#7;
    http://www.cancer.net/cancer-types/liver-cancer/statistics